Relationship between chemotherapy-induced peripheral neuropathy and physical activity in cancer survivors: A prospective longitudinal study

被引:1
作者
Kyota, Ayumi [1 ]
Kinjo, Taeko [2 ]
Kanda, Kiyoko [3 ]
Hosokawa, Mai [4 ]
Higuchi, Daisuke [5 ]
机构
[1] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan
[2] Gunma Univ Hosp, Div Nursing, Maebashi, Gunma, Japan
[3] Niigata Coll Nursing, Niigata, Japan
[4] Iwate Prefectural Univ, Fac Nursing, Grad Sch Nursing, Takizawa, Iwate, Japan
[5] Takasaki Univ Hlth & Welf, Dept Phys Therapy, Takasaki, Gunma, Japan
关键词
Peripheral neuropathy; Cancer; Exercise therapy; Pedometer; Numbness; FUNCTIONAL-ASSESSMENT; VALIDATION; SCALE;
D O I
10.1016/j.apjon.2024.100507
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: The purpose of this research is to evaluate the relationship between the degree of peripheral neuropathy associated with treatment and physical activity through the use of objective indicators such as wristband activity tracker and subjective evaluations obtained through interviews. Methods: This study included 11 patients with gynecological cancer, gastrointestinal cancer, and malignant lymphoma. Participants were requested to wear a wristband activity meter at two time points: early and midtreatment. Activity-meter step counts were compared with factors such as energy expenditure and Functional Assessment of Cancer Therapy-General during early and mid-treatment. Interviews were analyzed qualitatively and inductively. Results: There was no difference in the number of steps taken by participants in the early and mid-treatment periods (P = 0.050), but they took more steps in the mid-treatment period than in the early period. Participants expended more energy during mid-treatment than early treatment, but these differences were not significant. We noted a correlation between the number of steps and energy expenditure in the mid-treatment period (r = 0.883). Comparisons between measures showed significant differences in "Impact" between early and midtreatment on Distress and Impact Thermometer (P = 0.034). The impact of numbness on activity was assigned to three categories: loss of routine caused by numbness, coping with the numbness-related inconvenience using various resources, and acceptance of life with numbness with the support of others and self-strength. Conclusions: The participants devised strategies to maintain activities despite experiencing chemotherapy-induced peripheral neurotoxicity. The use of activity meters may enhance patient motivation, which in our opinion, is beneficial for self-care education.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Changes in Chemotherapy-induced Peripheral Neuropathy, Sleep Quality, and Quality of Life following Chemotherapy in Stomach Cancer Patients: a Prospective Study
    Oh, Pok Ja
    Lee, Jin
    Kim, Jeong Hye
    ASIAN ONCOLOGY NURSING, 2020, 20 (02) : 72 - 82
  • [32] Deleterious Effects of Higher Body Mass Index on Subjective and Objective Measures of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors
    Petrovchich, Iva
    Kober, Kord M.
    Wagner, Laura
    Paul, Steven M.
    Abrams, Gary
    Chesney, Margaret A.
    Topp, Kimberly
    Smoot, Betty
    Schumacher, Mark
    Conley, Yvette P.
    Hammer, Marilyn
    Levine, Jon D.
    Miaskowski, Christine
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 58 (02) : 252 - 263
  • [33] Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
    Ben-Horin, Idan
    Kahan, Peretz
    Ryvo, Larisa
    Inbar, Moshe
    Lev-Ari, Shahar
    Geva, Ravit
    INTEGRATIVE CANCER THERAPIES, 2017, 16 (03) : 258 - 262
  • [34] The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study
    McNeish, Brendan L.
    Dittus, Kim
    Mossburg, Jurdan
    Krant, Nicholas
    Steinharter, John A.
    Feb, Kendall
    Cote, Hunter
    Hehir, Michael K.
    Reynolds, Rebecca
    Redfern, Mark S.
    Rosano, Caterina
    Richardson, James K.
    Kolb, Noah
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (04)
  • [35] Association of Chemotherapy-Induced Peripheral Neuropathy with Diet Quality Among Post-Treatment Cancer Survivors
    Knoerl, Robert
    Ploutz-Snyder, Robert
    Smener, Liat
    Tofthagen, Cindy
    Zick, Suzanna
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2024, 76 (08): : 717 - 725
  • [36] Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
    Komatsu, Hiroko
    Yagasaki, Kaori
    Komatsu, Yasuhiro
    Yamauchi, Hideko
    Yamauchi, Teruo
    Shimokawa, Toshio
    Doorenbos, Ardith Z.
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2019, 6 (03) : 253 - 260
  • [37] Lagged Relationships Among Chemotherapy-Induced Peripheral Neuropathy, Sleep Quality, and Physical Activity During and After Chemotherapy
    Bulls, Hailey W.
    Hoogland, Aasha, I
    Small, Brent J.
    Kennedy, Brittany
    James, Brian W.
    Arboleda, Bianca L.
    Shahzad, Mian M. K.
    Gonzalez, Brian D.
    Jim, Heather S. L.
    ANNALS OF BEHAVIORAL MEDICINE, 2021, 55 (09) : 844 - 852
  • [38] Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
    Sanchez-Barroso, Lara
    Apellaniz-Ruiz, Maria
    Gutierrez-Gutierrez, Gerardo
    Santos, Maria
    Roldan-Romero, Juan M.
    Curras, Maria
    Remacha, Laura
    Calsina, Bruna
    Calvo, Isabel
    Sereno, Maria
    Merino, Maria
    Garcia-Donas, Jess
    Castelo, Beatriz
    Guerra, Eva
    Leton, Rocio
    Montero-Conde, Cristina
    Cascon, Alberto
    Inglada-Perez, Luca
    Robledo, Mercedes
    Rodriguez-Antona, Cristina
    ONCOLOGIST, 2019, 24 (08) : E784 - E792
  • [39] Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
    Griffith, Kathleen A.
    Merkies, Ingemar S. J.
    Hill, Elizabeth E.
    Cornblath, David R.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2010, 15 (04) : 314 - 325
  • [40] Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
    Alex Molassiotis
    Hui Lin Cheng
    Violeta Lopez
    Joseph S. K. Au
    Alexandre Chan
    Aishwarya Bandla
    K. T. Leung
    Y. C. Li
    K. H. Wong
    Lorna K. P. Suen
    Choi Wan Chan
    Janelle Yorke
    Carole Farrell
    Raghav Sundar
    BMC Cancer, 19